Early signs of liver failure after low-dose interferon alfa-2b for cutaneous melanoma

J Am Acad Dermatol. 2008 Mar;58(3):532-3. doi: 10.1016/j.jaad.2006.10.983.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Dose-Response Relationship, Drug
  • Early Diagnosis
  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Liver Failure / chemically induced*
  • Liver Failure / diagnosis*
  • Melanoma / drug therapy*
  • Recombinant Proteins
  • Skin Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins